Pacifico Biolabs nets $8m, targets alt-meat cost parity with brewery retrofit model
Pacifico Biolabs aims to unlock “a low-cost, rapidly scalable route to mass-market production,” says cofounder Zac Austin.
Pacifico Biolabs aims to unlock “a low-cost, rapidly scalable route to mass-market production,” says cofounder Zac Austin.
Silicon Valley Disposition lists a Windfall Bio online auction at the company’s San Mateo address, featuring “extremely high-end R&D instruments, bioreactor systems, lab equipment, and much more.”